RS
Rajiv Syal
About Rajiv Syal
Data last updated:
Rajiv Syal is a Designated Partner at Flxho Technologies Llp (since 2022), Director at Flxxho Ventures Private Limited (since 2026) and Designated Partner at Qalys Pharma Llp (since 2023). The companies operate in Internet and Pharma. The largest current company by reported revenue is Flxho Technologies Llp at ₹2.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 25 Nov 2022 | 2022 | ₹2.91 Cr (FY 2024) | Active | |
| Director | 25 Feb 2026 | 2026 | Active | ||
| Designated Partner | 20 Dec 2023 | 2021 | Active |
Board colleagues of Rajiv Syal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nipun Bhandari | 10030400 | Flxho Technologies Llp , Flxxho Ventures Private Limited | Designated Partner |
| Rashmi Sharma | 10030401 | Flxho Technologies Llp , Flxxho Ventures Private Limited and 1 more | Designated Partner |
| Aryan Mahajan | 09197228 | Qalys Pharma Llp | Designated Partner |
| Rajesh Mahajan | 02000634 | Qalys Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajiv Syal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajiv Syal
Rajiv Syal currently holds 3 directorships: Flxho Technologies Llp (Designated Partner, since 25 Nov 2022, revenue ₹2.91 Cr (FY 2024)); Flxxho Ventures Private Limited (Director, since 25 Feb 2026); Qalys Pharma Llp (Designated Partner, since 20 Dec 2023).
Rajiv Syal was first appointed on 25 Nov 2022 as Designated Partner at Flxho Technologies Llp. The most recent appointment on record is 25 Feb 2026 at Flxxho Ventures Private Limited.
The current boards of Rajiv Syal's companies include Nipun Bhandari (Flxho Technologies Llp), Rashmi Sharma (Flxho Technologies Llp), Aryan Mahajan (Qalys Pharma Llp), Rajesh Mahajan (Qalys Pharma Llp).